ACE

DEVICE2 trials

Sponsors

Lymphoma Study Association, Cochlear

Conditions

CD20-Positive Large B-Cell LymphomaHearing Loss

Phase 3

Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma

TerminatedNCT00169169

Lymphoma Study AssociationCD20-Positive Large B-Cell Lymphoma

Start: 1999-10-31End: 2005-08-31Target: 430Updated: 2005-09-15

Unknown Phase

Sound Processing Innovations in Adult and Paediatric Cochlear Implant Recipients.

CompletedNCT05476328

CochlearHearing Loss

Start: 2020-01-22End: 2023-03-17Updated: 2025-02-13